{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T17:39:41Z","timestamp":1773077981055,"version":"3.50.1"},"reference-count":31,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2005,8,24]],"date-time":"2005-08-24T00:00:00Z","timestamp":1124841600000},"content-version":"vor","delay-in-days":23,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Experimental Allergy"],"published-print":{"date-parts":[[2005,8]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Background\n\t\t\t\t\t<\/jats:bold> Allergen\u2010induced T\u2010helper type 2 (Th2) responses can be inhibited with Th1 directing vaccines. However, studies comparing the efficacy of the different adjuvants have not been performed in detail.<\/jats:p><jats:p><jats:bold>Objective\n\t\t\t\t\t<\/jats:bold> For this reason we compare the effects of live Bacillus\u2013Calmette\u2013Guerin(BCG), heat\u2010killed (hk)\u2010BCG, CpG\u2010ODN (oligodeoxynucleotide) or PPD on the development of allergen\u2010induced Th2 responses in mice.<\/jats:p><jats:p><jats:bold>Methods\n\t\t\t\t\t<\/jats:bold> Ovalbumin (OVA)\u2010specific allergic responses were induced in C57BL\/6 mice by two intraperitoneally (i.p.) applications of OVA\/alum followed by the intranasal challenge with OVA. The different Th1\u2010inducing adjuvants were applied to the mice together with OVA\/alum i.p. during the OVA\u2010sensitization period and, subsequently, different parameters of allergic immune responses were evaluated.<\/jats:p><jats:p><jats:bold>Results\n\t\t\t\t\t<\/jats:bold> All the adjuvants were effective in inhibiting the development of allergen\u2010induced airway eosinophilia, mucous production and, with the exception of PPD, also airway hyper\u2010reactivity, when they were applied together with OVA\/alum. However, allergen\u2010specific IgG1 and IgE serum levels were only reduced in live BCG\u2010 and PPD\u2010treated mice. Suppression of airway eosinophilia was not observed in IFN\u2010\u03b3\u2010 or IL\u201012\u2010deficient mice (hk\u2010BCG, CpG\u2010ODN and PPD). Interestingly, live BCG was still able to suppress allergen\u2010induced Th2 responses in the absence of either IFN\u2010\u03b3 or IL\u201012. When mice vaccinated with the different adjuvants together with OVA\/alum were subjected to a second period of OVA\/alum immunization, only live and hk\u2010BCG were able to efficiently suppress the development of airway inflammation. This effect could be adoptively transferred by splenic CD4<jats:sup>+<\/jats:sup> T cells.<\/jats:p><jats:p><jats:bold>Conclusions\n\t\t\t\t\t<\/jats:bold> Taken together our data suggest that live BCG&gt;hk\u2010BCG&gt;CpG\u2010ODN &gt;PPD are effective in suppressing allergen\u2010induced Th2 responses. The degree of suppression and the component of the Th2 response affected (airway inflammation vs. the production of allergen\u2010specific IgE and IgG1) were dependent upon the adjuvant used and how it was applied. Our results contribute to the design of novel vaccines protecting humans from developing allergic disorders.<\/jats:p>","DOI":"10.1111\/j.1365-2222.2005.02287.x","type":"journal-article","created":{"date-parts":[[2005,8,24]],"date-time":"2005-08-24T12:27:54Z","timestamp":1124886474000},"page":"1003-1013","source":"Crossref","is-referenced-by-count":44,"title":["Vaccinations with T\u2010helper type 1 directing adjuvants have different suppressive effects on the development of allergen\u2010induced T\u2010helper type 2 responses"],"prefix":"10.1111","volume":"35","author":[{"given":"C. M.","family":"Trujillo\u2010Vargas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. D.","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Bickert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Palmetshofer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Grunewald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. R.","family":"Ramirez\u2010Pineda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Polte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Wohlleben","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. J.","family":"Erb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,8,24]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2008.02971.x"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0952-7915(02)00385-0"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.296.5567.490"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0602-625"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(03)01869-4"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)80533-6"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.187.4.561"},{"key":"e_1_2_6_9_2","first-page":"223","article-title":"Vaccination with heat\u2010killed Listeria as adjuvant reverses established allergen\u2010induced airway hyperreactivity and inflammation","volume":"164","author":"Hansen G","year":"2000","journal-title":"role of CD8+ T cells and IL-18"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.170.9.4601"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1078\/1438-4221-00257"},{"key":"e_1_2_6_12_2","first-page":"618","article-title":"Atopic disorders","volume":"22","author":"Wohlleben G","year":"2001","journal-title":"a vaccine around the corner?"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2002.129371"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2222.2003.01727.x"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.170.6.3289"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2222.2002.01389.x"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2002.01732.x"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.156.3.9606031"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-1759(98)00204-X"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(99)70022-9"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1471-4906(03)00067-X"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002810000053"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.190.9.1309"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.1.207"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.4.4.469"},{"key":"e_1_2_6_26_2","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1128\/iai.36.3.966-970.1982","article-title":"Induction of alpha and beta interferons during the hyporeactive state of gamma interferon by Mycobacterium bovis BCG cell wall fraction in Mycobacterium bovis BCG\u2010sensitized mice","volume":"36","author":"Nakane A","year":"1982","journal-title":"Infect Immun"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200324659"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00073.2003"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm987"},{"key":"e_1_2_6_30_2","first-page":"584","article-title":"Therapeutic effects of BCG vaccination in adult asthmatic patients","volume":"88","author":"Choi IS","year":"2002","journal-title":"a randomized, controlled trial"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2004.01861.x"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2004.01875.x"}],"container-title":["Clinical &amp; Experimental Allergy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2222.2005.02287.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2222.2005.02287.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T00:31:53Z","timestamp":1697243513000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2222.2005.02287.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["10.1111\/j.1365-2222.2005.02287.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2222.2005.02287.x","archive":["Portico"],"relation":{},"ISSN":["0954-7894","1365-2222"],"issn-type":[{"value":"0954-7894","type":"print"},{"value":"1365-2222","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,8]]}}}